Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis

Background: Treatment during acute or early human immunodeficiency virus (HIV)-1 infection is associated with immunologic and virologic benefits. Objective: To evaluate darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) efficacy/safety among patients with acute or early HIV-1 infec...

Full description

Bibliographic Details
Main Authors: Keith Dunn, Rachel Rogers, Richard Bruce Simonson, Donghan Luo, Shubin Sheng, Purnima T. Kassam, Sareh Seyedkazemi, Hélène Hardy
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:HIV Research & Clinical Practice
Subjects:
hiv-1
acute hiv-1 infection
early hiv-1 infection
rapid initiation
darunavir
Online Access:http://dx.doi.org/10.1080/25787489.2021.1915652

Internet

http://dx.doi.org/10.1080/25787489.2021.1915652

Similar Items